fig2

Targeting tumor-draining lymph node to overcome resistance to cancer immunotherapy: an update

Figure 2. Mechanisms of ICI resistance mediated by excluded T cell tumor infiltration. (A) Chemokine axis dysregulation limits T cell recruitment; (B) Intratumoral vascular structural abnormalities hinder T cell trafficking and infiltration; (C) Immunosuppressive cytokine secretion driven by carcinogenic signaling pathways constrains T cell infiltration; (D) ECM fibrosis confines T cell penetration; (E) Intratumoral metabolic stress suppresses T cell infiltration, with lactate accumulation particularly impairing T cell metabolism and effector function, thereby limiting antitumor immunity. Created in BioRender. Wang, L. (2025) https://BioRender.com/5savrs6. ICI: Immune checkpoint inhibitor; ECM: extracellular matrix.

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/